Combined oral contraceptives and liver cancer

• Main Authors: Ramiro Molina, Luis Martinez, Oriana Salas, Aifredo Dabancens, Tao Yun, Chen Zhi‐Heng, Hu Yong‐Wei, Alvaro Cuadros, Nubia Aristizabal, Baruch Modan, Elaine Ron, Esther Alfandary, J. G. Mati, Patrick Kenya, Alfred Kungu, D. Gatei, Patrick A. Ibeziako, A. A. Abioye, T. A. Junaid, Patrick U. Aghadiuno, Ruben A. Apelo, Julietta R. De LaCruz, Jose Baens, Benjamin D. Canlas, Suporn Silpisornkosol, Tieng Pardthaisong, Boonlong Sivasomboom, Choti Theetranont, Banpot Boosiri, Supawat Chutivongse, Pramuan Virutamasen, Chansuda Wongsrichanalai, Sermsri Sindhvananda, Suporn Koetsawang, Duangdao Rachawat, Orawan Kiriwat, Nivat Chantarakul, P. P. Anthony, David B. Thomas, Janet L. Stanford, Roberta M. Ray, Elizabeth A. Noonan, Susan Holck
• 其他作者: Facultad de Medicina de la Universidad de Chile
• 格式: Article
• 出版: 2018
• 主題: Biochemistry, Genetics and Molecular Biology; Medicine
• 在線閱讀: https://repository.li.mahidol.ac.th/handle/123456789/15733
• 機構: Mahidol University

A multi‐national, hospital‐based, case‐control study was conducted to evaluate the possible relationships of steroid contraceptives to 6 neoplasms. Based on data from 122 newly diagnosed cases of primary liver cancer and 802 matched controls, the relative risk of liver cancer in women who had ever u...